Intl Medication Company Profile
What is the competitive landscape for INTL MEDICATION
INTL MEDICATION has fifty-eight approved drugs.
Summary for Intl Medication
| US Patents: | 0 |
| Tradenames: | 44 |
| Ingredients: | 40 |
| NDAs: | 58 |
Drugs and US Patents for Intl Medication
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intl Medication Sys | EPINEPHRINE | epinephrine | SOLUTION;INTRAVENOUS | 211363-001 | Aug 15, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Intl Medication | LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE | lidocaine hydrochloride | INJECTABLE;INJECTION | 017702-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Intl Medication Sys | DEXTROSE 50% | dextrose | INJECTABLE;INJECTION | 203451-001 | Mar 26, 2021 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Intl Medication | ISOETHARINE HYDROCHLORIDE | isoetharine hydrochloride | SOLUTION;INHALATION | 086651-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
